AF Association News & Events
Atrial fibrillation patients benefit most from this treatment
Patients who receive a specific form of treatment for the common heart condition known as atrial fibrillation have increased survival and reduced hospitalisation rates, according to new international ... These results are a major finding with implications for the treatment of atrial fibrillation (AF) worldwide.
Life-prolonging treatment brings new hope for heart patients
A global study is providing new hope for heart patients who suffer from a common condition. Atrial fibrillation occurs when the heart beats irregularly and can increase the risk of stroke and heart failure. One form of treatment is catheter ablation - a procedure that involves inserting a tube into the heart ...
NHS could save £81m a year though new tech designed to prevent strokes
This includes Kardia Mobile, a small device that is able to detect irregular heart rhythms – or atrial fibrillation (AF) – in 30 seconds, by recording the electrical activity of the heart through a patient's fingertips and sending the data to an app. The app then allows heart rhythm recordings to be viewed, saved ...
Cardiac Rhythm News - 16 February 2018
All the latest from the Cardiac Rhythm News.
GPs set to gain access to 30-second fingertip AF testing device
A new tech device to speed up atrial fibrillation diagnosis has the potential to save the NHS £2bn, its developer has claimed.
Call for Elections
The European Heart Rhythm Association (EHRA) is pleased to announce the opening of its call for Elections: Executive Board positions for the period 2018-2020.
Smartphone ECG device KardiaMobile rolled out to NHS to combat atrial fibrillation
AliveCor has announced that it has begun the rollout of its KardiaMobile technology to the NHS via the UK’s Academic Health Science Networks (AHSNs) as part of a project funded by NHS England to accelerate diagnosis of atrial fibrillation (AF), a potentially fatal heart rhythm condition.
Patient first to benefit from new heart device
A PATIENT has become the first in the UK to be implanted with an innovative cardiac device to modulate the heart’s beat.
NHS rolls out KardiaMobile to accelerate detection of arrhythmia
KardiaMobile, developed by AliveCor, is a credit card sized device able to detect AF in 30 seconds, by recording the electrical activity of the heart through a person's fingertips and sending the data to a smartphone/tablet app. The app allows heart rhythm recordings to be viewed, saved and shared with ...
Cardiac Insight, Inc. Welcomes Renowned Atrial Fibrillation Cardiologists Professor John Camm and Albert L. Waldo, MD to its Scientific Advisory Board
Cardiac Insight, Inc., a leading U.S. developer of wearable medical devices and diagnostic software, announced today the company continues to garner global interest in its approach to cardiac care, and has added renowned cardiologists and atrial fibrillation (AFib) specialists, Professor John Camm and Albert L. Waldo, MD, PhD (Hon.) to its Scientific Advisory Board.